Jian Zhuang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jian Zhuang has a total of 127 co-authors. Here are the top co-authors by number of shared publications:
Hailong Qiu
Department of Cardiovascular Surgery, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China
12 shared publicationsShusheng Wen
Guangdong Provincial Key Laboratory of South China Structural Heart Disease, Guangzhou, China
10 shared publicationsTianyu Chen
Department of Cardiovascular Surgery, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China
10 shared publicationsJianzheng Cen
Guangdong Provincial Key Laboratory of South China Structural Heart Disease, Guangzhou, China
8 shared publicationsJimei Chen
Guangdong Provincial Key Laboratory of South China Structural Heart Disease, Guangzhou, China
8 shared publicationsXiaobing Liu
Department of Cardiovascular Surgery, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China; Guangdong Provincial Key Laboratory of South China Structural Heart Disease, Guangzhou, China
8 shared publications
Latest Publications
- Open Access
- 27 February 2026
- Published by Elsevier in Revista Portuguesa de Cardiologia
- Vol. 45 (6) , 333-334
Reply to the Letter to the Editor “Sex imbalance in a large Fontan cohort: Biological reality or marker of inequitable care?”
- 27 February 2026
- Published by Elsevier in Revista Portuguesa de Cardiologia
- Vol. 45 (6) , 333-334
Open AccessReply to the Letter to the Editor “Sex imbalance in a large Fontan cohort: Biological reality or marker of inequitable care?”
- Open Access
- 1 January 2026
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 18 (1) , 5
Continuous suture technique for aortic valve replacement in patients with small aortic annulus
Original Article Continuous suture technique for aortic valve replacement in patients with small aortic annulus Shenghua Liang, Kan Zhou, Peizeng Liu, Jue Yang, Jian Zhuang, Zerui Chen
- 1 January 2026
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 18 (1) , 5
Open AccessContinuous suture technique for aortic valve replacement in patients with small aortic annulus
Original Article Continuous suture technique for aortic valve replacement in patients with small aortic annulus Shenghua Liang, Kan Zhou, Peizeng Liu, Jue Yang, Jian Zhuang, Zerui Chen
- 18 November 2025
- Published by Springer Nature in Pediatric Research
- Vol. 99 (7) , 1-4
Congenitally corrected transposition of the great arteries: outcomes after single ventricle palliation
Background Congenitally corrected transposition of the great arteries (ccTGA) is a rare congenital cardiac anomaly. As a viable alternative for complex anatomical variants, the outcomes of single-ventricle palliation (SVP) in ccTGA patients remain poorly defined. Methods We conducted a single-center retrospective analysis of ccTGA patients who underwent SVP between January 2004 and December 2020. Results A total of 73 patients were included. Patients with ccTGA undergoing SVP demonstrated excellent early and mid-term outcomes, with no observed mortality and freedom from MAEs of 96.0%, 93.6%, and 78.0% at 5, 10, and 15 years postoperatively, respectively. Conclusions SVP can achieve excellent early and mid-term outcomes in carefully selected ccTGA patients. When complex biventricular repair is not feasible, SVP represents a safe and effective alternative. Impact Single-ventricle palliation can achieve excellent outcomes in selected congenitally corrected transposition of the great arteries. When complex biventricular repair is not feasible, SVP represents a safe and effective alternative.
- 18 November 2025
- Published by Springer Nature in Pediatric Research
- Vol. 99 (7) , 1-4
Congenitally corrected transposition of the great arteries: outcomes after single ventricle palliation
Background Congenitally corrected transposition of the great arteries (ccTGA) is a rare congenital cardiac anomaly. As a viable alternative for complex anatomical variants, the outcomes of single-ventricle palliation (SVP) in ccTGA patients remain poorly defined. Methods We conducted a single-center retrospective analysis of ccTGA patients who underwent SVP between January 2004 and December 2020. Results A total of 73 patients were included. Patients with ccTGA undergoing SVP demonstrated excellent early and mid-term outcomes, with no observed mortality and freedom from MAEs of 96.0%, 93.6%, and 78.0% at 5, 10, and 15 years postoperatively, respectively. Conclusions SVP can achieve excellent early and mid-term outcomes in carefully selected ccTGA patients. When complex biventricular repair is not feasible, SVP represents a safe and effective alternative. Impact Single-ventricle palliation can achieve excellent outcomes in selected congenitally corrected transposition of the great arteries. When complex biventricular repair is not feasible, SVP represents a safe and effective alternative.
- Open Access
- 10 September 2025
- Published by Elsevier in Revista Portuguesa de Cardiologia
- Vol. 44 (11) , 661-668
20 years of experience with the Fontan procedure: Risk factors for adverse outcomes
- 10 September 2025
- Published by Elsevier in Revista Portuguesa de Cardiologia
- Vol. 44 (11) , 661-668
Open Access20 years of experience with the Fontan procedure: Risk factors for adverse outcomes
- 14 June 2025
- Published by Elsevier in Revista Española de Cardiología (English Edition)
- Vol. 79 (4) , 382-384
Fontan completion in adulthood in patients with a functional single ventricle
- 14 June 2025
- Published by Elsevier in Revista Española de Cardiología (English Edition)
- Vol. 79 (4) , 382-384
Fontan completion in adulthood in patients with a functional single ventricle
- Open Access
- 14 March 2025
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 16, 1539046
Gut microbiota community and metabolic profiles in direct total cavopulmonary connection and Fontan circulation: a cross-sectional study in the single center
Background: This study aimed to evaluate the impact of the direct total cavopulmonary connection (dTCPC) procedure on the gut microbiome and metabolome. It also sought to elucidate the features of the gut microbiota community and metabolic profiles in Fontan circulation.Methods: We randomly recruited 45 participants above 14 years old undergoing Fontan procedure by typical extracardiac conduit (TCPC group, n = 15), direct total cavopulmonary connection (dTCPC group, n = 16) procedure and healthy control (control group, n = 14) in our institution between May 2023 and October 2023. 16S rRNA amplicon sequencing and untargeted metabolites measurement were performed on their fecal sample.Results: The four alpha diversity indexes showed no statistical significance between the dTCPC and TCPC groups (p > 0.05). Orthogonal partial least squares discriminant analysis (OPLS-DA) followed by permutation testing indicated an overfitting effect in the model between the dTCPC and TCPC groups. We observed significant differences in the Chao1 index (p = 0.0236), the ACE index (p = 0.0236), and the unweighted beta diversity (p = 0.0099) between the Fontan group and healthy control group. Strains of Fusobacterium were significantly overrepresented in the Fontan group [with linear discriminant analysis (LDA) scores exceeding (log10) >3]. Functional enrichment analysis revealed a significant overrepresentation of several metabolic pathways. These pathways predominantly included those related to amino acid metabolism, such as histidine metabolism, glycine, serine, and threonine metabolism, and cysteine and methionine metabolism. Additionally, the biosynthesis of unsaturated fatty acids was also notably enriched.Conclusion: The dTCPC procedure demonstrated similar gut microbiota composition and metabolic profiles to the traditional ECC procedure in Fontan patients. Notably, the increased abundance of Fusobacterium, reduced microbial biodiversity, and altered metabolic profiles of amino acids and unsaturated fatty acids in the alimentary canal may serve as distinctive characteristics of patients who have undergone Fontan circulation. These findings provide valuable insights into the long-term physiological consequences of Fontan procedure and may inform future clinical management strategies.
- 14 March 2025
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 16, 1539046
Open AccessGut microbiota community and metabolic profiles in direct total cavopulmonary connection and Fontan circulation: a cross-sectional study in the single center
Background: This study aimed to evaluate the impact of the direct total cavopulmonary connection (dTCPC) procedure on the gut microbiome and metabolome. It also sought to elucidate the features of the gut microbiota community and metabolic profiles in Fontan circulation.Methods: We randomly recruited 45 participants above 14 years old undergoing Fontan procedure by typical extracardiac conduit (TCPC group, n = 15), direct total cavopulmonary connection (dTCPC group, n = 16) procedure and healthy control (control group, n = 14) in our institution between May 2023 and October 2023. 16S rRNA amplicon sequencing and untargeted metabolites measurement were performed on their fecal sample.Results: The four alpha diversity indexes showed no statistical significance between the dTCPC and TCPC groups (p > 0.05). Orthogonal partial least squares discriminant analysis (OPLS-DA) followed by permutation testing indicated an overfitting effect in the model between the dTCPC and TCPC groups. We observed significant differences in the Chao1 index (p = 0.0236), the ACE index (p = 0.0236), and the unweighted beta diversity (p = 0.0099) between the Fontan group and healthy control group. Strains of Fusobacterium were significantly overrepresented in the Fontan group [with linear discriminant analysis (LDA) scores exceeding (log10) >3]. Functional enrichment analysis revealed a significant overrepresentation of several metabolic pathways. These pathways predominantly included those related to amino acid metabolism, such as histidine metabolism, glycine, serine, and threonine metabolism, and cysteine and methionine metabolism. Additionally, the biosynthesis of unsaturated fatty acids was also notably enriched.Conclusion: The dTCPC procedure demonstrated similar gut microbiota composition and metabolic profiles to the traditional ECC procedure in Fontan patients. Notably, the increased abundance of Fusobacterium, reduced microbial biodiversity, and altered metabolic profiles of amino acids and unsaturated fatty acids in the alimentary canal may serve as distinctive characteristics of patients who have undergone Fontan circulation. These findings provide valuable insights into the long-term physiological consequences of Fontan procedure and may inform future clinical management strategies.
- 27 January 2025
- Published by Elsevier in Revista Española de Cardiología (English Edition)
- Vol. 78 (8) , 741-744
Risk factors for the progression of aortic regurgitation following surgical repair of sinus of Valsalva aneurysms. Analysis of 317 cases
- 27 January 2025
- Published by Elsevier in Revista Española de Cardiología (English Edition)
- Vol. 78 (8) , 741-744
Risk factors for the progression of aortic regurgitation following surgical repair of sinus of Valsalva aneurysms. Analysis of 317 cases
- 1 November 2024
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 66 (5)
Ascending aortic length predicts adverse outcomes in type A intramural haematoma
OBJECTIVES: Ascending aortic length has recently been recognized as a novel predictor of adverse events in aortic diseases, but its prognostic value in type A intramural haematoma is unknown. We aimed to evaluate the association between ascending aortic length and outcomes in patients with type A intramural haematoma initially managed medically. METHODS: We retrospectively analysed patients with acute type A intramural haematoma. Ascending aortic length was measured by computed tomography. The primary outcome was aortic progression, defined as aortic intervention or aortic-related death. RESULTS: A total of 98 patients were enrolled. During a median follow-up of 2.6 years, aortic progression occurred in 27 patients (27.6%), i.e. 9 events per 100 patient-years. Patients with ascending aortic length ≥11 cm had significantly higher rates of aortic progression [54.2% (20.9 events per 100 patient-years) vs 18.9% (6.1 events per 100 patient-years), P = 0.001], surgical intervention (45.8% vs 12.2%, P = 0.001) and presence of ulcer-like projection (25.0% vs 2.7%, P = 0.002) compared to those with ascending aortic length <11 cm. Kaplan–Meier analysis demonstrated lower progression-free survival in the ascending aortic length ≥11 cm group (P = 0.0021). Ascending aortic length had a sensitivity of 61.9% and specificity of 77.8% for predicting aortic progression, with an area under the curve of 0.756 (95% confidence interval 0.649–0.862). CONCLUSIONS: Ascending aortic elongation may identify a high-risk subgroup of acute type A intramural haematoma patients initially managed medically who could potentially benefit from early surgery. Ascending aortic length should be considered in the risk stratification and management of these patients.
- 1 November 2024
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 66 (5)
Ascending aortic length predicts adverse outcomes in type A intramural haematoma
OBJECTIVES: Ascending aortic length has recently been recognized as a novel predictor of adverse events in aortic diseases, but its prognostic value in type A intramural haematoma is unknown. We aimed to evaluate the association between ascending aortic length and outcomes in patients with type A intramural haematoma initially managed medically. METHODS: We retrospectively analysed patients with acute type A intramural haematoma. Ascending aortic length was measured by computed tomography. The primary outcome was aortic progression, defined as aortic intervention or aortic-related death. RESULTS: A total of 98 patients were enrolled. During a median follow-up of 2.6 years, aortic progression occurred in 27 patients (27.6%), i.e. 9 events per 100 patient-years. Patients with ascending aortic length ≥11 cm had significantly higher rates of aortic progression [54.2% (20.9 events per 100 patient-years) vs 18.9% (6.1 events per 100 patient-years), P = 0.001], surgical intervention (45.8% vs 12.2%, P = 0.001) and presence of ulcer-like projection (25.0% vs 2.7%, P = 0.002) compared to those with ascending aortic length <11 cm. Kaplan–Meier analysis demonstrated lower progression-free survival in the ascending aortic length ≥11 cm group (P = 0.0021). Ascending aortic length had a sensitivity of 61.9% and specificity of 77.8% for predicting aortic progression, with an area under the curve of 0.756 (95% confidence interval 0.649–0.862). CONCLUSIONS: Ascending aortic elongation may identify a high-risk subgroup of acute type A intramural haematoma patients initially managed medically who could potentially benefit from early surgery. Ascending aortic length should be considered in the risk stratification and management of these patients.
- Open Access
- 4 February 2024
- Published by IMR Press in Frontiers in Bioscience-Landmark
- Vol. 29 (2) , 49
Myogenin Regulates DUSP13 to Inhibit Apoptosis Induced by Reactive Oxygen Species
Background: Myogenin is well known as a crucial transcription factor in skeletal muscle development, yet its other biological functions remain unexplored. Previous research showed that myogenin suppresses apoptosis induced by angiotensin II in human induced pluripotent stem cell-derived cardiomyocytes, and offered a new perspective on myogenin’s role in cardioprotection. However, the detailed mechanism of this cardioprotection, especially under oxidative stress, is still unclear. Methods: In this study, hydrogen peroxide (H2O2) was used to generate reactive oxygen species in myogenin-overexpressing cardiomyocytes. The apoptosis was examined by flow cytometry. Transcriptome sequencing (RNA-seq) was performed to identify genes regulated by myogenin. Western blotting was used to detect the protein level of DUSP13 and the phosphorylation level of p38 mitogen-activated protein kinase (MAPK). The dual-luciferase reporter assay and ChIP assay were used to confirm the binding of myogenin to the promoter region of DUSP13. DUSP13 overexpression and knockdown assays were performed to study its anti-apoptotic role. Results: Flow cytometry analysis of apoptosis showed that overexpressing myogenin for 24 and 48 hours decreased the apoptotic ratio by 47.9% and 63.5%, respectively, compared with untreated controls. Transcriptome sequencing performed on cardiomyocytes that expressed myogenin for different amounts of time (6, 12, 24, and 48 hours) identified DUSP13 as being up-regulated by myogenin. Western blotting showed that overexpression of myogenin increased the expression of DUSP13 and decreased the phosphorylation level of p38 MAPK. A dual-luciferase reporter assay proved that myogenin bound directly to the promoter region of DUSP13 and led to strong relative luciferase activity. Direct expression of DUSP13A and DUSP13B significantly reduced the rates of apoptosis and necrosis in cells treated with H2O2. Knockdown of DUSP13B significantly increased the rate of apoptosis in cells treated with H2O2. Conclusions: The present findings suggest that myogenin might attenuate apoptosis induced by reactive oxygen species by up-regulating DUSP13 and inactivating the p38 MAPK pathway.
- 4 February 2024
- Published by IMR Press in Frontiers in Bioscience-Landmark
- Vol. 29 (2) , 49
Open AccessMyogenin Regulates DUSP13 to Inhibit Apoptosis Induced by Reactive Oxygen Species
Background: Myogenin is well known as a crucial transcription factor in skeletal muscle development, yet its other biological functions remain unexplored. Previous research showed that myogenin suppresses apoptosis induced by angiotensin II in human induced pluripotent stem cell-derived cardiomyocytes, and offered a new perspective on myogenin’s role in cardioprotection. However, the detailed mechanism of this cardioprotection, especially under oxidative stress, is still unclear. Methods: In this study, hydrogen peroxide (H2O2) was used to generate reactive oxygen species in myogenin-overexpressing cardiomyocytes. The apoptosis was examined by flow cytometry. Transcriptome sequencing (RNA-seq) was performed to identify genes regulated by myogenin. Western blotting was used to detect the protein level of DUSP13 and the phosphorylation level of p38 mitogen-activated protein kinase (MAPK). The dual-luciferase reporter assay and ChIP assay were used to confirm the binding of myogenin to the promoter region of DUSP13. DUSP13 overexpression and knockdown assays were performed to study its anti-apoptotic role. Results: Flow cytometry analysis of apoptosis showed that overexpressing myogenin for 24 and 48 hours decreased the apoptotic ratio by 47.9% and 63.5%, respectively, compared with untreated controls. Transcriptome sequencing performed on cardiomyocytes that expressed myogenin for different amounts of time (6, 12, 24, and 48 hours) identified DUSP13 as being up-regulated by myogenin. Western blotting showed that overexpression of myogenin increased the expression of DUSP13 and decreased the phosphorylation level of p38 MAPK. A dual-luciferase reporter assay proved that myogenin bound directly to the promoter region of DUSP13 and led to strong relative luciferase activity. Direct expression of DUSP13A and DUSP13B significantly reduced the rates of apoptosis and necrosis in cells treated with H2O2. Knockdown of DUSP13B significantly increased the rate of apoptosis in cells treated with H2O2. Conclusions: The present findings suggest that myogenin might attenuate apoptosis induced by reactive oxygen species by up-regulating DUSP13 and inactivating the p38 MAPK pathway.